Life-Sciences-Benelux.com
The Benelux Life Sciences Web Portal

This is a free web portal for the life sciences in Belgium, The Netherlands and Luxembourg... » read more

Sofinnova Partners Closes €445m Late-stage Crossover Fund (2021-03-03)
> The pioneering growth capital fund is the largest dedicated to biopharma and medtech companies seeking scale-up financing in Europe > With over €2 billion under management, Sofinnova Partners continues its expansion across the entire value chain of life scienc...
Philips: Shez Partovi Chief Innovation & Strategy Officer (2021-03-02)
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Shez Partovi will join Philips’ Executive Committee, effective from March 22, 2021, in order to succeed Jeroen Tas as Chief Innovation & Strategy Officer, effective fro...
Hologic Acquires European MDx Firm Diagenode for €130m (2021-03-01)
-- Transaction Expands and Diversifies Hologic’s Diagnostic Business Across Test Menu, Customer Segments and Geography – Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has acquired Diagenode, a privately held, European...
Oxular Ltd Raises £27m Financing Led by Forbion (2021-03-01)
> Led by specialist life sciences investor, Forbion > Investment will fund Phase 2 human clinical studies evaluating Oxular's 12-month treatment for diabetic macular edema, and accelerate development of early-product pipeline Oxular Limited ("Oxular"), a le...
Mosa Meat Adds $10m in Final Closing of $85m Series B (2021-02-23)
Mosa Meat, the European food technology company that introduced the world’s first cultivated beef hamburger in 2013, announced the third and last closing of its Series B funding. This third closing of $10m brings the total raised in the round to $85m. Investors ...
CureVac Starts Rolling Submission of CVnCoV with EMA (2021-02-12)
> Rolling submission with EMA initiated to accelerate time to potential marketing authorization of CVnCoV > Submission of CVnCoV pre-clinical data package marks start of the rolling process CureVac N.V. (Nasdaq: CVAC), a global biopharmaceutical company dev...
Forbion Announces New Gene Therapy Company VectorY (2021-02-10)
> Fully integrated gene therapy offering, including platform technology, pipeline development, and manufacturing capabilities > Targeting muscular and neurodegenerative disorders > Amsterdam-based company seeded by Forbion, the pioneering gene therapy investo...
Galapagos/Gilead Discontinue Phase 3 Trials of Ziritaxestat (2021-02-10)
Galapagos NV (Euronext & NASDAQ: GLPG) and Gilead Sciences (NASDAQ: GILD) today announced the decision to halt the ISABELA Phase 3 clinical studies with the investigational autotaxin inhibitor ziritaxestat in patients with idiopathic pulmonary fibrosis. The decisio...
Pan Cancer T Launched as Spin-off from Erasmus MC (2021-02-08)
– Dutch biotech company developing first-in-class T-cell Receptor (TCR) T-cell therapies – Seed investment by Swanbridge Capital and Van Herk Ventures with support from Health~Holland Pan Cancer T B.V., a biotech spin-off from the Erasmus Medical Center fou...
First Closing of V-Bio Fund 2 with €78m in Commitments (2021-02-04)
> V-Bio Fund 2 will ensure seamless continuation of investment activities in early-stage European life sciences companies > V-Bio Ventures announces expansion of executive team, with Shelley Margetson joining as Managing Partner V-Bio Ventures (V-Bio) ...

Life-Sciences-Benelux.com is your doorway to the Benelux life sciences!

[LSBNL] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Benelux countries Belgium, The Netherlands and Luxembourg.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSBNL] is 100% Made in Germany!

» Start here with the latest News!

Picture Kentro Design Corporate and Web Design Berlin 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)